Camber Pharma Launches Generic Canasa® Suppositories
Piscataway, NJ, August 5, 2020– Camber Pharmaceuticals is pleased to announce that it has launched Mesalamine suppositories, which is the generic version of Canasa® suppositories. Mesalamine suppositories is used to treat mild to moderate ulcerative colitis.
Mesalamine Suppositories are available from Camber in 1000mg- 30ct blister pack.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection





